Related Experiment Video
Updated: Dec 19, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Novelties in arterial hypertension management in the last decade]
J M Krzesinski1, A Saint-Remy1
1Service de Néphrologie, Dialyse et Transplantation, CHU Liège, Belgique.
Insights
Effective hypertension management remains a challenge, with recent guidelines emphasizing patient education, home monitoring, and combination therapies. Improved blood pressure control is crucial for cardiovascular protection.
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Hypertension is a primary cardiovascular risk factor with insufficient control despite numerous management efforts.
- No new antihypertensive drugs have been released in the past decade, shifting focus to non-pharmacological interventions.
- High blood pressure, often termed the 'silent killer,' necessitates improved control strategies.
Purpose of the Study:
- To review current strategies for managing hypertension.
- To highlight the impact of recent guidelines on hypertension treatment.
- To emphasize the importance of multi-faceted approaches for better blood pressure control.
Main Methods:
- Review of recent guidelines and therapeutic approaches for hypertension management.
- Emphasis on patient validation, home blood pressure monitoring, and therapeutic education.
- Discussion of treatment decisions based on cardiovascular risk and the role of combination therapy.
Main Results:
- New, simplified guidelines released in 2018 aim to improve hypertension control.
- European guidelines maintain a blood pressure target below 140/90 mmHg for most patients.
- Combination therapy in a single pill is recommended for enhanced treatment efficacy.
Conclusions:
- Improved blood pressure control requires a collaborative effort involving patients, families, nurses, and pharmacists.
- Adherence to guidelines and combination therapies are key to achieving optimal cardiovascular protection.
- Enhanced patient education and home monitoring are vital for managing this prevalent cardiovascular risk factor.
Abstract:
Hypertension remains one of the most important cardiovascular risk factors. In spite of many efforts for its management, the control of high blood pressure remains insufficient. In the last decade, no new antihypertensive drug was released. The main effort to improve blood pressure control was put on the validation of the hypertensive status, the stimulation of home blood pressure measurement and the therapeutic education of the patients. The releasing in 2018 of new guidelines, which are clear and more simple, would help more efficiently fight against hypertension, the still present silent killer. In Europe, the usual blood pressure target has been kept, i.e.a lowering of blood pressure below 140/90 mmHg in all fit patients whatever their age. Lower target could be proposed according to the patient tolerance. Treatment is decided according to cardiovascular risk evaluation. Quickly a combination of two antihypertensive agents in a single pill is proposed to improve efficacy of the treatment. We also need the help of the family, nurses and pharmacists to increase the chance of a better blood pressure control, which is necessary to get an optimal cardiovascular protection.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers

